ScholarIQanswers from OpenAlex

Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study

PaperCitations, authors & open-access status

Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study have?

ScholarIQcitation count

Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study has 7 citations in the OpenAlex counts ScholarIQ stores.

When was Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study published?

ScholarIQyear

Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study has 2025 year in the ScholarIQ index.

What is the open-access status of Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study?

ScholarIQoa status

Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study has hybrid oa status in the ScholarIQ index.

What is the DOI of Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study?

ScholarIQdoi

The DOI for Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study is on the source record.

What is the PMID of Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study?

ScholarIQpmid

The PMID for Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study is on the source record.

What is the OpenAlex record for Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study?

ScholarIQopenalex

The OpenAlex for Factors associated with HPV vaccine hesitancy: A nationally representative cross-sectional study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial